Targeting SARS-CoV-2 nonstructural protein 15 endoribonuclease: an in silico perspective

The newly emerged human coronavirus, SARS-CoV-2, had begun to spread last year and sparked worldwide. In this study, molecular docking is utilized to test some previously approved drugs against the SARS-CoV-2 nonstructural protein 15 (Nsp15). We screened 23 drugs, from which three (saquinavir, valru...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Future Virol
Egile Nagusiak: Mahmud, Shafi, Elfiky, Abdo A, Amin, Al, Mohanto, Sumon Chandro, Rahman, Ekhtiar, Acharjee, Uzzal Kumar, Saleh, Abu
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Future Medicine Ltd 2021
Gaiak:
Short Communication
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC8285111/
https://ncbi.nlm.nih.gov/pubmed/34290822
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2217/fvl-2020-0233
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak